Dicaris Adults 150 mg (Levamisole)

Dicaris Adults 150 Mg (Levamisole) — Uses, Dosage, Side Effects & Complete Patient Guide

What Is Dicaris Adults 150 Mg?

Some medications do one thing well, and then some medications do several things well. Dicaris Adults 150 Mg firmly belongs in the second category.

Dicaris Adults 150 Mg is an antiparasitic and immunomodulatory tablet containing Levamisole as its active ingredient. It is the adult-strength formulation of the well-known Dicaris brand — specifically dosed to meet the therapeutic requirements of adult patients. While the pediatric version (Dicaris Children 50 Mg) is tailored for younger patients, Dicaris Adults 150 Mg delivers the full therapeutic dose needed for effective treatment in adults — typically as a single tablet taken once.

Levamisole has been in clinical use since the late 1960s and has earned a reputation as one of the most versatile antiparasitic compounds available. Originally developed purely as an anthelmintic — a drug that expels parasitic worms — it was later discovered to possess remarkable immune-regulating properties, opening the door to a broader range of clinical applications.

In its antiparasitic role, Dicaris Adults 150 Mg is primarily used to treat roundworm (Ascaris lumbricoides) infections — one of the most prevalent intestinal parasitic infections worldwide. It is also used against hookworm infections and, in specialized clinical contexts, as an immunomodulatory agent in conditions where the immune system needs recalibration rather than suppression.

If you’ve been prescribed Dicaris Adults 150 Mg and want a thorough, clear understanding of what you’re taking — or if you’re a healthcare professional or caregiver looking for comprehensive reference information — this guide covers everything you need to know.

How Does Dicaris Adults 150 Mg Work?

Levamisole operates through two distinct and clinically meaningful mechanisms, which is a large part of what makes it so uniquely valuable.

Antiparasitic Mechanism — Neuromuscular Paralysis of Worms: Levamisole is a nicotinic acetylcholine receptor agonist — a term that sounds complex but describes something elegantly simple. It mimics the action of acetylcholine, a natural neurotransmitter, at the nerve-muscle junctions of parasitic worms.

When Levamisole binds to these receptors in the worm, it causes sustained, irreversible depolarization of the worm’s muscle cells. The result is spastic paralysis — the worm’s muscles contract rigidly and permanently. Unable to move, feed, or maintain its position in the intestine, the paralyzed worm is swept along with normal intestinal contents and expelled through bowel movements.

The selective toxicity of Levamisole is what makes it safe for humans — these nicotinic receptors are far more abundant and pharmacologically distinct in helminth (worm) neuromuscular systems compared to humans. The drug targets the parasite’s biology with high specificity.

Immunomodulatory Mechanism — Immune System Recalibration: Beyond its antiparasitic action, Levamisole has a genuinely fascinating secondary property. It acts as an immunostimulant — but not in a crude, non-specific way. Rather, it selectively restores and enhances cell-mediated immunity in individuals whose immune response is depressed or dysregulated.

Specifically, Levamisole:

• Enhances T-lymphocyte proliferation and activity — boosting the adaptive immune response
• Stimulates macrophage function — improving the immune system’s ability to identify and destroy pathogens and abnormal cells
• Restores natural killer (NK) cell activity
• Normalizes cytokine production — the chemical signaling molecules that coordinate immune responses

This makes Levamisole particularly useful not just as a worm treatment but as a tool for managing conditions where immune dysregulation plays a central role.

What Does Dicaris Adults 150 Mg Treat?

Roundworm Infection (Ascariasis) — Primary Indication: Ascariasis, caused by Ascaris lumbricoides, is the most common intestinal worm infection in the world, with an estimated 800 million to 1 billion people affected globally at any given time. While it is more prevalent in children, adults are by no means immune, particularly those living in or traveling to endemic regions with poor sanitation.

In adults, roundworm infections can present with:

• Chronic or recurrent abdominal pain and cramping
• Bloating and excessive gas
• Nausea, vomiting, or loss of appetite
• Irregular bowel movements
• Unexplained weight loss
• General fatigue and malaise
• In heavy infections, intestinal obstruction is a medical emergency

Dicaris Adults 150 Mg delivers a single-dose treatment that effectively paralyzes and clears roundworms from the intestine. For uncomplicated infections, one tablet taken once is typically all that’s needed.

Hookworm Infection (Ancylostomiasis / Necatoriasis) Hookworm infections are contracted when larvae living in contaminated soil penetrate the skin — most commonly through bare feet. The larvae migrate through the bloodstream to the lungs, are coughed up and swallowed, and eventually mature in the small intestine where they attach to the intestinal wall and feed on blood.

In adults, chronic hookworm infection causes:

• Iron-deficiency anemia — often the most prominent feature
• Chronic fatigue and weakness
• Shortness of breath
• Pale skin and conjunctiva
• Protein malnutrition
• Reduced work capacity and productivity

Levamisole effectively treats hookworm infections, though the degree of efficacy can vary slightly by hookworm species. Your doctor may recommend a follow-up stool examination to confirm clearance.

Adjunct Therapy in Colorectal Cancer (Historical Use) One of the more medically significant applications of Levamisole in adult medicine was its use alongside 5-fluorouracil (5-FU) as adjuvant chemotherapy for Stage III colorectal cancer. This combination demonstrated improved survival outcomes in clinical trials and helped establish Levamisole as a drug with genuine oncological relevance.

While it has largely been superseded by more effective modern chemotherapy regimens, this historical use highlighted Levamisole’s immunostimulatory properties and its ability to enhance the body’s response to cancer treatment.

Immune Restoration in Recurrent Infections In adults with evidence of impaired cell-mediated immunity — manifesting as recurrent bacterial, viral, or fungal infections — Levamisole has been used to help restore immune competence. Its ability to stimulate T-lymphocyte and macrophage activity makes it a valuable adjunct in these situations.

Rheumatoid Arthritis (Historical Adjunct Use) Levamisole was once investigated and used as a disease-modifying agent in rheumatoid arthritis due to its immunomodulatory properties. While it has been largely replaced by more targeted biologics and DMARDs in modern rheumatology, it demonstrated meaningful anti-inflammatory effects in some patients — further evidence of its immune-regulating capabilities.

Vitiligo (Adjunct Therapy) Vitiligo is an autoimmune skin condition in which the immune system attacks melanocytes — the cells responsible for skin pigmentation — causing patches of depigmented skin. Levamisole has been studied as an adjunct in vitiligo management, where its immunomodulatory properties help regulate the aberrant autoimmune response. Some studies have shown improved repigmentation outcomes when Levamisole is combined with topical treatments.

Dicaris Adults 150 Mg Dosage — How to Take It?

Getting the dosage right is straightforward for antiparasitic use — and more nuanced for immunomodulatory applications.

For Roundworm (Ascariasis) and Hookworm Infections:

• Standard adult dose: One tablet (150 mg) as a single dose
• This single-dose regimen is one of the most convenient aspects of Dicaris Adults — no multi-day course, no complicated schedule
• In most cases of uncomplicated roundworm infection, one dose is curative
• Your doctor may recommend a stool examination 2–4 weeks after treatment to confirm complete clearance
• If worms persist, a repeat dose may be prescribed

For Immunomodulatory Indications: Dosing for immune-related conditions is more individualized and depends on the specific condition, the patient’s weight, and clinical response:

• A common immunomodulatory regimen is 150 mg given on alternate days or 150 mg once weekly, depending on the indication
• Long-term use requires regular blood monitoring — particularly complete blood counts (CBC)
• Always follow your specialist’s dosing instructions precisely for non-antiparasitic indications

Practical Tips for Taking Dicaris Adults 150 Mg:

• Can be taken with or without food — taking it with a light meal may reduce the likelihood of nausea
• Swallow the tablet whole with a full glass of water, or chew if the formulation permits — check your specific product packaging
• Avoid alcohol on the day of treatment and for at least 48 hours afterward — Levamisole can cause a disulfiram-like reaction with alcohol
• Avoid driving or operating heavy machinery on the day of treatment if you experience dizziness or drowsiness
• Store tablets at room temperature, away from direct sunlight and moisture
• For single-dose antiparasitic treatment, there is no need to take a laxative or follow any special dietary preparation

Side Effects of Dicaris Adults 150 Mg:-

For short-term antiparasitic use, Dicaris Adults 150 Mg is generally very well tolerated. The majority of people who take a single dose for worm treatment experience few or no side effects. Side effects become a more significant consideration with prolonged use for immunomodulatory purposes.

Common Side Effects (Typically Mild and Transient):

• Nausea
• Abdominal discomfort or cramping
• Vomiting
• Diarrhea
• Headache
• Dizziness or lightheadedness
• Mild fatigue

These effects usually resolve within 24 to 48 hours and require no specific intervention beyond rest and adequate hydration.

Side Effects Associated With Prolonged Use:

• Mouth ulcers (aphthous stomatitis) — a well-recognized and fairly common complaint with long-term Levamisole therapy
• Flu-like symptoms — persistent low-grade fever, muscle aches, chills
• Skin rash — sometimes appearing characteristically on the face, ears, or extremities
• Altered or metallic taste
• Hair thinning — reported with extended use
• Joint pain and stiffness
• Fatigue and general malaise
• Gastrointestinal symptoms persisting beyond the initial treatment period

Serious Side Effects — Critical Warning Signs:

Agranulocytosis: This is the most serious and potentially life-threatening adverse effect associated with Levamisole — particularly relevant with prolonged use. Agranulocytosis is a dramatic and dangerous reduction in neutrophils (a type of white blood cell critical for fighting bacterial infections).

Adults on long-term Levamisole therapy must be vigilant for:

• Sudden high fever — especially if it comes on rapidly
• Severe sore throat — disproportionate to any apparent illness
• Painful mouth ulcers — multiple or unusually severe
• Unusual or recurrent infections — infections that seem more severe than expected or that don’t resolve normally
• Extreme and unexplained fatigue
• Pallor

If any of these symptoms develop, stop Dicaris Adults immediately and seek urgent medical attention. A complete blood count (CBC) must be performed without delay. Agranulocytosis can be fatal if not identified and managed promptly.

ANCA-Associated Vasculitis: Long-term Levamisole use has been associated with ANCA-associated vasculitis — an autoimmune inflammation of blood vessels. This can present as unusual skin lesions (particularly affecting the ears, nose, and cheeks), joint pain, and kidney involvement. Any unexplained skin changes during Levamisole therapy should be reported to your doctor promptly.

Levamisole-Induced Leukoencephalopathy: Though primarily documented in the context of Levamisole-contaminated cocaine use, there are rare reports of neurological complications including confusion, cognitive changes, and white matter brain lesions. While extremely rare in therapeutic use, any significant neurological changes should be reported immediately.

Severe Allergic Reaction (Anaphylaxis): Though rare, severe allergic reactions are possible. Signs include sudden swelling of the face, lips, tongue, or throat, difficulty breathing, rapid heartbeat, and severe hives. This is a medical emergency requiring immediate attention — call emergency services without delay.

Precautions — Who Should Use Dicaris Adults With Extra Care?

Pregnant Women: Levamisole is generally not recommended during pregnancy — particularly during the first trimester. While large-scale human teratogenicity data is limited, animal studies and the principle of caution mean most physicians avoid it during pregnancy unless the benefit clearly and substantially outweighs the risk. Always inform your doctor if you are pregnant, planning pregnancy, or suspect you may be pregnant.

Breastfeeding Women: Levamisole passes into breast milk in small amounts. While the infant exposure from a single antiparasitic dose is likely to be low, it is advisable to discuss timing with your doctor. Some guidelines recommend avoiding breastfeeding for 24–48 hours after a single dose or for the duration of prolonged therapy.

Elderly Patients: Older adults may metabolize Levamisole more slowly due to reduced liver and kidney function. Lower doses or extended dosing intervals may be appropriate, and closer monitoring for side effects — particularly agranulocytosis — is warranted.

Patients With Liver Disease: Since Levamisole undergoes hepatic metabolism, patients with liver impairment — including cirrhosis, hepatitis, or significant liver fibrosis — may have altered drug clearance. Dose adjustment and liver function monitoring are essential in these patients.

Patients With Kidney Disease: Renal impairment can affect the elimination of Levamisole metabolites. Patients with significant kidney disease should use Dicaris Adults under close medical supervision with appropriate dose consideration.

Patients With Blood Disorders: Any pre-existing condition affecting white blood cell production or function — including neutropenia, aplastic anemia, or bone marrow suppression — represents a significant risk factor for agranulocytosis with Levamisole. Use is generally contraindicated or requires extremely careful hematological monitoring.

Patients With Autoimmune Conditions: While Levamisole’s immunostimulatory properties are therapeutically useful in some autoimmune conditions, they can be unpredictable in others. Patients with pre-existing autoimmune disorders should only use Dicaris Adults under specialist supervision.

Patients With Epilepsy: Levamisole may lower the seizure threshold in susceptible individuals. If you have a history of epilepsy or seizures, inform your neurologist and prescribing doctor before starting Dicaris Adults.

Drug Interactions — What to Discuss With Your Doctor?

Warfarin and Anticoagulants: Levamisole can potentiate the anticoagulant effect of Warfarin, increasing bleeding risk. If you are on anticoagulation therapy, more frequent INR monitoring is essential during Levamisole treatment — even for a single-dose course.

Alcohol: A disulfiram-like reaction has been reported when Levamisole is combined with alcohol — characterized by facial flushing, nausea, vomiting, rapid heartbeat, and general discomfort. Avoid all alcohol on the day of treatment and for at least 48 hours afterward.

Phenytoin: Levamisole may increase plasma levels of Phenytoin, potentially enhancing both its therapeutic effects and its toxicity. If you take Phenytoin for seizure management, close monitoring of drug levels and clinical response is advisable.

Corticosteroids: When used alongside corticosteroids — as in nephrotic syndrome or inflammatory conditions — the interaction between Levamisole’s immune stimulation and corticosteroid-mediated immune suppression requires careful clinical management and monitoring.

Fluorouracil (5-FU): In oncology settings, the Levamisole plus 5-FU combination carries enhanced toxicity profiles including increased risk of mucositis and myelosuppression. This combination must only be used under specialist oncology supervision.

Immunosuppressants (Cyclosporine, Azathioprine, Methotrexate): Combining Levamisole with immunosuppressant medications creates complex, potentially unpredictable immune interactions. Specialist oversight is mandatory in these situations.

Carbamazepine: May accelerate the hepatic metabolism of Levamisole, potentially reducing its efficacy. Dose adjustments may be necessary if both drugs are used concurrently.

Always provide your doctor and pharmacist with a complete and current list of every medication, supplement, herbal product, and over-the-counter drug you are taking.

Frequently Asked Questions About Dicaris Adults 150 Mg?

Is one tablet really enough to treat a roundworm infection in an adult?

Yes — for most uncomplicated roundworm infections in adults, a single 150 mg dose of Levamisole is highly effective. The drug works rapidly, paralyzing worms within hours and allowing them to be expelled naturally within 24 to 48 hours. A follow-up stool test confirms clearance.

How will I know the treatment has worked?

You may notice worms in your stool within 1 to 2 days of taking Dicaris Adults — this is normal and actually confirms the drug is working. Symptoms like abdominal discomfort and bloating should begin improving within a few days. A stool examination 2 to 4 weeks after treatment provides definitive confirmation.

Can I take Dicaris Adults 150 mg on an empty stomach?

Yes — Levamisole can be taken with or without food. However, taking it with a light meal or snack may reduce the chance of nausea, particularly if you have a sensitive stomach.

Do I need to repeat the dose?

For straightforward roundworm infections, a single dose is usually sufficient. However, your doctor may recommend a repeat dose or a follow-up examination if symptoms persist or if the initial stool test remains positive after treatment.

Is Dicaris Adults 150 mg the same as Vitilex 50 Mg or other Levamisole brands?

Yes — Dicaris Adults 150 Mg, Vitilex 50 Mg, and other Levamisole-containing products share the same active ingredient. The differences lie in the dose strength, manufacturer, formulation, and brand name. Dicaris Adults is specifically formulated at the 150 mg strength appropriate for adult single-dose antiparasitic treatment.

Should I be worried about agranulocytosis from a single dose?

The risk of agranulocytosis is primarily associated with prolonged, repeated use of Levamisole — not with a single antiparasitic dose. For short-term antiparasitic treatment, the safety profile of Dicaris Adults is excellent. The agranulocytosis concern is most relevant for patients on long-term immunomodulatory therapy.

Disclaimer:-

This article is intended for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.